[News Brief] Otsuka Pharmaceutical Co., Ltd. Announces FDA Priority Review of Centanafadine NDA for ADHD
Otsuka has stated that the U.S. Food and Drug Administration (FDA) has accepted for priority review its New Drug Application…
Otsuka has stated that the U.S. Food and Drug Administration (FDA) has accepted for priority review its New Drug Application…
Johnson & Johnson has published an Innovation feature detailing the development of Shockwave Medical’s intravascular lithotripsy (IVL) system, which uses…
South Korean healthcare company Kwangdong Pharmaceutical has entered the Singapore market with its Vita500 range of vitamin products, marking an…
The European Commission has approved a 7.2 mg once-weekly maintenance dose of Wegovy® (semaglutide) for adults with obesity across all…
The NurseFirst medical helpline trial in Singapore has redirected more than 800 non-urgent medical calls to general practitioners and community…
Meiji Seika Pharma Co., Ltd. plans to establish a local subsidiary in Singapore in spring 2026 to strengthen its commercial…
Metagen, Inc. has unveiled its Gut Design Programme in ASEAN at the Global Knowledge Hub Forum in Singapore, aiming to…
Hyphens Pharma has secured exclusive rights from Japan-based Maruho to register and commercialise the shingles treatment Amenalief ® Tab 200…
Private cord blood bank Cordlife has had its cord blood banking service licence renewed for one year by the Ministry…
An international research team led from Nanyang Technological University, Singapore (NTU Singapore) has identified a biological mechanism that may help…